Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
December 19, 2019 07:00 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s...
Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting
December 09, 2019 10:00 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s...
Molecular Templates to Present at Two December Investor Conferences
November 26, 2019 08:00 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s...
Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering
November 21, 2019 07:00 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates, Inc. Announces Proposed Public Equity Offering
November 20, 2019 16:01 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and...
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
November 18, 2019 07:00 ET
|
Molecular Templates, Inc.
-Molecular Templates to receive $38 million upfront payment, including equity investment, with potential for additional milestone and royalty payments on future sales- BOSTON and AUSTIN, Texas, Nov. ...
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results
November 12, 2019 17:00 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular,” “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the...
Molecular Templates Hosting Analyst & Investor Meeting
November 07, 2019 16:27 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s...
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
September 23, 2019 16:30 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s...
Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results
August 12, 2019 16:30 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular,” “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the...